SIMPONI® injection schedule for UC1
Week 0
2 (100-mg) injections
Week 2
1 (100-mg) injection
Week 6 and every 4 weeks thereafter
1 (100-mg) injection
L-histidine–based injection buffer
SIMPONI® requires nearly half the injections compared
with Humira® (adalimumab) (per first year of treatment)1,2
SIMPONI® (golimumab)
INDUCTION
Week 0
Week 2
1 injection at Week 6 and every 4 weeks thereafter
15
TOTAL INJECTIONS PER
FIRST YEAR
Humira® (adalimumab)
Day 1
Day 15
1 injection every 2 weeks
28
Total Injections Per First Year*
This presentation is not intended to compare the safety, efficacy, or indications of these treatments. While these factors are important, there are additional considerations for selecting a treatment. Please refer to each product’s Prescribing Information for additional information, including recommended dosing and administration.
SIMPONI® is administered by subcutaneous (SC) injection. The induction dosage regimen is 200 mg at Week 0, followed by 100 mg at Week 2, and then 100 mg maintenance therapy every 4 weeks.
Humira® is administered by SC injection. The induction dosage regimen is 160 mg at Week 0, followed by 80 mg at Week 2, and then 2 weeks later begin a maintenance dose of 40 mg every other week.
Humira is a registered trademark of AbbVie Inc.
*Number of Humira® induction injections calculated using a 80-mg/0.8-mL single-use prefilled pen.